Concurrent infections of hepatitis C and HIV in hepatitis B patients in the north-east of Iran

Tropical Doctor

Volumn 41, Issue 3, 2011, Pages 129-131

  Moradi, A ^a   Khodabakhshi, B ^b   Sadeghipour, M ^b   Besharat, S ^b   Tabarraei, A ^c  

^a Infectious Diseases Research Centre   (United States)

^b Department of Infectious Diseases ^*  (United States)

^c GOLESTAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS C ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ADULT; ANTIBODY DETECTION; ARTICLE; CLINICAL ASSESSMENT; DIAGNOSTIC ACCURACY; DISEASE TRANSMISSION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RATE; INFECTION RISK; IRAN; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MORBIDITY; MORTALITY; REAL TIME POLYMERASE CHAIN REACTION; SCREENING; SENSITIVITY AND SPECIFICITY; VIRUS LOAD; VIRUS PARTICLE;

ADULT; FEMALE; HEPACIVIRUS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HEPATITIS C; HEPATITIS C ANTIBODIES; HIV ANTIBODIES; HIV INFECTIONS; HIV-1; HUMANS; IRAN; MALE; MIDDLE AGED;

HEPATITIS B VIRUS; HEPATITIS C VIRUS;

EID: 79960173340     PISSN: 00494755     EISSN: 17581133     Source Type: Journal    
DOI: 10.1258/td.2011.100418     Document Type: Article

References (22)

1. Chironna M, Germinario C, Lopalco PL, Carrozzini F, Barbuti S, Quarto M. Prevalence rates of viral hepatitis infection in refugee Kurds from Iraq and Turkey. Infection, 2003;31:70-4
2. Hashemi M, Alavi SM, Ghavami S, de Serres FJ, Salehi M, Doroudi. High prevalence of alpha 1 antitrypsin phenotypes in viral hepatitis B infected patients in Iran. Hepatol Res, 2005;33:292-7
3. Ott MJ, Aruda M. Hepatitis B vaccine. J Pediatr Health Care, 1999; 13:211-16
4. Lavanchy D. Worldwide epidemiology of HIV infection, disease burden and vaccine prevention. J Clin Virol, 2005;34:1-3
5. Zandi M, Adib-Hajbagheri M, Memarian R, Nejhad AK, Alavian SM. Effects of a self-care program on quality of life of cirrhosis patients referring to Tehran hepatitis center. Health Qual Life Outcomes, 2005;3:35
6. Alavian SM. Optimal therapy for hepatitis C. Hepatitis Monthly, 2004;4:41-2
7. Lok AS, Mcmahon BJ. Chronic hepatitis B. Hepatology, 2001;34: 1225-41
8. Highleyman L. HIV and hepatitis C coinfection. BETA, 2003;15: 32-44
9. Chu CJ, Lee SD. Hepatitis B virus/hepatitis C virus coinfection: epidemiology, clinical features, viral interactions and treatment. J Gastroenterol Hepatol, 2008;23:512-20
10. Roshandel GH, Semnani Sh, Abdollahi N, et al., The Prevalence of concurrent infections in HBV-HDV and HCV in Golestan Province. Med Uni Sci J, 2008;9:61-6 (in Persian)
11. Hassanpour A, Arasteh A, Ghorbani S. Assessment of HIV, HBV and HCV infection prevalence in patients in surgery Ward. Sci J Kurdistan Univ, 2003;8:25-31 (in Persian)
12. Arora U, Mann A. Prevalence of hepatitis B virus, hepatitis B virus, HIV in patients of chronic liver diseases in Amritsar. JIACM, 2007;8:29-31
13. La Tori G, Miele L, Chiaradia G, et al., Socio-demografic edeterminants of coinfections by HIV, hepatitis B and hepatitis C viruses in central Italian prisoners. BMC Infectious Dis, 2007;7:100
14. Alavian SM, Etemadi A. HIV/HBV, HIV/HCV and HIV/HTLV-1 co infection among injecting drug user patients hospitalized at the injectious disease ward of a training hospital in Iran. Pak J Med Sci, 2007;23:510-13
15. Chandra M, Khaja MN, Hussain MM, et al., Prevalence of hepatitis B and C viral infections in Indian patients with chronic renal failure. Intervirology, 2004;47:374-6
16. Jilg W, Sieger E, Zachoval R, Schätzl H. Individuals with antibodies against hepatitis B core antigen as the only serological marker for hepatitis B infection: high percentage of carriers of hepatitis B and C virus. J Hepatol, 1995;23:14-20
17. French AL, Operskalski E, Peters M, et al., Isolated hepatitis B core antibody is associated with HIV and ongoing but not resolved hepatitis C virus infection in a cohort of US women. J Infect Dis, 2007;195:1437-42
18. Piroth L, Binquet C, Vergne M, et al., The evolution of hepatitis B virus serological patterns and the clinical relevance of isolated antibodies to hepatitis B core antigen in HIV infected patients. J Hepatol, 2002;36:681-6
19. Araujo NM, Branco-Vieira M, Silva AC, et al., Occult hepatitis B virus infection in HIV-infected patients: evaluation of biochemical, virological and molecular parameters. Hepatol Res, 2008;38:1194-203
20. Lo Re V 3rd, Frank I, Gross R, et al., Prevalence, risk factors, and outcomes for occult hepatitis B virus infection among HIV infected patients. J Acquir Immune Defic Syndr, 2007;44:315-20
21. Rockstroh JK. Influence of viral hepatitis on HIV infection. J Hepatol, 2007;44:S25-7
22. Thio CL, Netski DM, Myung J, Seaberg EC, Thomas DL. Changes in hepatitis B virus DNA levels with acute HIV infection. Clin Infect Dis, 2004;38:1024-9